VERNEY-CARRON S.C.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.6 EUR | +18.75% |
|
+18.75% | -12.64% |
| 2022 | Biopharmaceutical Group Pharnext Names New Chair/CEO; Shares Surge 63% | MT |
| 2022 | Cybergun S.A. completed the acquisition of Verney-Carron S.A.. | CI |
Valuation
| Fiscal Period: February | 2017 | 2018 | 2021 | 2022 |
|---|---|---|---|---|
| Capitalization 1 | 3.555 | 5.244 | 4.088 | 3.178 |
| Enterprise Value (EV) 1 | 5.69 | 10.54 | 8.741 | 7.831 |
| P/E ratio | 5.26 x | -14.2 x | -2.71 x | -1.72 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.25 x | 0.46 x | 0.42 x | 0.33 x |
| EV / Revenue | 0.41 x | 0.92 x | 0.91 x | 0.81 x |
| EV / EBITDA | 6.8 x | -27.6 x | -7.01 x | 151 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | 0.41 x | 0.65 x | 0.77 x | 0.49 x |
| Nbr of stocks (in thousands) | 444 | 444 | 444 | 543 |
| Reference price 2 | 8.000 | 11.80 | 9.200 | 5.850 |
| Announcement Date | 5/24/18 | 5/2/19 | 10/7/21 | 9/13/22 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: February | 2017 | 2018 | 2021 | 2022 |
|---|---|---|---|---|
| Net sales 1 | 14 | 11.41 | 9.636 | 9.636 |
| EBITDA 1 | 0.8371 | -0.3826 | -1.246 | 0.0519 |
| EBIT 1 | 0.6515 | -0.5768 | -1.484 | -0.1863 |
| Operating Margin | 4.65% | -5.05% | -15.41% | -1.93% |
| Earnings before Tax (EBT) 1 | 0.4699 | -0.6932 | -2.056 | -2.056 |
| Net income 1 | 0.6759 | -0.3683 | -1.845 | -1.845 |
| Net margin | 4.83% | -3.23% | -19.14% | -19.14% |
| EPS 2 | 1.521 | -0.8288 | -3.395 | -3.395 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 5/24/18 | 5/2/19 | 10/7/21 | 9/13/22 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: February | 2017 | 2018 | 2021 | 2022 |
|---|---|---|---|---|
| Net Debt 1 | 2.13 | 5.3 | 4.65 | 4.65 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.55 x | -13.85 x | -3.733 x | 89.67 x |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | 8.05% | -4.37% | - | -28.5% |
| ROA (Net income/ Total Assets) | 2.68% | -2.32% | - | -0.79% |
| Assets 1 | 25.21 | 15.91 | - | 233.6 |
| Book Value Per Share 2 | 19.60 | 18.30 | 11.90 | 11.90 |
| Cash Flow per Share 2 | 2.660 | 0.0800 | 3.080 | 3.080 |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 5/24/18 | 5/2/19 | 10/7/21 | 9/13/22 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -12.64% | 3.75M | |
| +20.41% | 4.51B | |
| +28.06% | 1.04B | |
| +4.86% | 599M | |
| +118.31% | 311M | |
| -22.43% | 304M | |
| +20.00% | 301M |
- Stock Market
- Equities
- MLVER Stock
- Financials Verney-Carron S.C.A.